hsa-mir-1912: Hsa-mir-1912 is a miRNA that has been found to be up-regulated in certain conditions [PMC6921333]. In a study, it was identified as one of the up-regulated miRNAs along with hsa-mir-383, hsa-mir-490, hsa-mir-488, hsa-mir-1265 [PMC6921333]. Another study also confirmed the up-regulation of hsa-mir-1912 along with hsa-miR-31-5p, hsa-miR-224-5p, hsa-miR-205-5p, and others [PMC7378055]. The expression of hsa-mir-1912 was found to be significantly increased after etoposide treatment [PMC5386646]. Furthermore, it was observed that the expression of hsa-mir-1912 was upregulated in response to various apoptosis-inducing agents [PMC5386646]. In summary, hsa-mir-1912 is a miRNA that has been shown to be up-regulated in certain conditions and in response to apoptosis-inducing agents. It has been identified as one of the up-regulated miRNAs along with other specific miRNAs. The highest upregulation of its expression was observed after etoposide treatment. These findings suggest that hsa-mir-1912 may play a role in apoptosis and could potentially serve as a biomarker for certain conditions or treatment responses. However, further research is needed to fully understand its function and clinical implications.